Advanced Wound Care Management: Enhanced approach to medication
Market Overview According to a new report published by Reports Monitor titled, “Advanced Wound Care Management Market by Product Type, Wound Type, and End-User: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the advanced wound care management market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025.
The science of wound care management that comprises wound prevention and wound healing is a certainly intricate speciality. This demands practitioner to have a highly deep knowledge about physiological and pharmacological concepts so as to offer the patient with the most suitable treatment and care. This therapy along with regulating hydrated condition, also aid in keeping constant temperature, eliminates dead tissues, permits the oxygen flow, safeguards the injured site from harmful microorganisms and reduces the pain associated with dressing changes.
Increasing cases of diabetes and related chronic wounds and rising accidental incidences are the vital factors drive the growth of the market. Moreover, increasingly innovative and modified wound care products and engagement of people into awareness programs for advanced wound care treatment and management, increasing disposable income, surging expenditure on healthcare and collaborations & advent of product launch collectives stimulates the growth of the market. However, high cost of advanced wound care product and procedures might create an hurdle in the growth of the market.
According to National Health Institute and CDC estimates, in 2015 approximately 2.5 million people were cured from pressure ulcers alone in the U.S. thus huge populace suffering from various kinds of deep and chronic wounds,, growing geriatric populations, swift adoption of newly launched healthcare products and high spending of healthcare facilities leads the growth of the market in North America.
The global advanced wound care management market is segmented on the basis of product type, wound type, end-user and geography. In terms of product type the market is mainly distributed into moist wound dressings, wound therapy devices and active wound care. Moist wound dressings are separated into foam, film, hydrocolloid, hydrogel, alginate and collagen. Wound therapy devises are classified into pressure relief devices, electrical stimulation devices, hyperbaric oxygen equipment, negative pressure wound therapy system and other wound therapy devices. Active wound care is spilt into artificial skin & substitutes and topical agents. Artificial skin & substitutes is further bifurcated into allografts & xenografts, and autografts. Based on wound type the market is segregated into surgical wounds, ulcers, burns, traumatic wounds and others. Ulcers are again diverted into pressure ulcers, venous ulcers, and diabetic foot ulcers. According to end-use segment market is segment into hospitals& clinics, home care setting and others.
Competitive Analysis The key players running in the market include Molnlycke Healthcare, Coloplast, Cardinal Health, Smith & Nephew, Medtronic, Acelity L.P., Integra Lifesciences, Hematris Wound Care, Wound Care Technologies, PAUL HARTMANN and Lohmann & Rauscher. Recently in 2017 Smith & Nephew, advanced wound care & surgical devices company announced European launch of MolecuLight i:X. It is handheld imaging device which promptly measures wound surface area and gives visualization of presence of potentially harmful bacteria in it. The technology is evidence based decision making in wound care and bringing a massage to new area of healthcare.
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.